CivicaScript, a Utah-based nonprofit company focused on bringing lower-cost generic medicines to US consumers, announced on Tuesday the appointment of Brent J Eberle, RPh, MBA as its new president, effective 30 September.
Eberle currently serves as chief pharmacy officer at Navitus Health Solutions.
Additionally, Eberle has played a significant role in shaping drug policy at both the state and national levels. He testified before the US House of Representatives Energy and Commerce Subcommittee on Health, sharing his expertise on drug pricing, and served on the Wisconsin Governor's Task Force on Reducing Prescription Drug Prices, a bipartisan group focused on addressing the high cost of prescription medications.
Eberle is to replace CivicaScript's first president, Gina Guinasso, JD, who left in June.
Ned McCoy, Civica president and chief executive officer, said: "We are thrilled to have a business and pharmacy executive of Brent's calibre on board to lead CivicaScript on its important next stage of growth. Given CivicaScript's strong member relationship with Navitus, Brent knows the business and embodies the mission – an ideal foundation to hit the ground running."
Biocon seeking partner to test semaglutide generics in China
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
ANI Pharmaceuticals launches generic Baclofen Oral Suspension
Mikart adds Fette double-sided tablet presses
Biocon Biologics enters five-year partnership with Sandoz Australia
Mallinckrodt names new directors
Rottendorf Pharma enhances operations with Rockwell Automation's FactoryTalk PharmaSuite MES